This inventor holds 1 USPTO granted patent. Top assignee: Cha University Industry-Academic Cooperation Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Jung Jae Ko in Endometrial Health
Introduction
Jung Jae Ko is an innovative inventor based in Yongin, South Korea. He has made significant contributions to the field of reproductive health through his research and inventions. His work focuses on enhancing endometrial blood flow, which is crucial for successful implantation during pregnancy.
Latest Patents
Jung Jae Ko holds a patent for a composition comprising botulinum toxin or a salt thereof aimed at increasing the endometrial blood flow rate. This composition is designed to improve the implantation potential of embryos, making it particularly beneficial for patients facing subfertility or infertility. The application of this composition directly to the endometrium can enhance blood flow and improve the chances of successful embryonic implantation. Given that botulinum toxin is already widely used in cosmetic procedures, the research on its human toxicity may be expedited, making this invention economically and industrially valuable.
Career Highlights
Jung Jae Ko is affiliated with the Cha University Industry-Academic Cooperation Foundation, where he continues to advance his research in reproductive health. His work is characterized by a commitment to improving patient outcomes in the field of fertility.
Collaborations
He collaborates with notable colleagues, including Youn Jung Kang and Hwa Seon Koo, who contribute to his research endeavors and help in the development of innovative solutions in reproductive health.
Conclusion
Jung Jae Ko's contributions to the field of reproductive health through his innovative patent demonstrate his dedication to improving the lives of individuals facing fertility challenges. His work not only advances scientific understanding but also offers practical solutions for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile